4//SEC Filing
Hagopian Henry III 4
Accession 0001104659-22-096653
CIK 0001477845other
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 8:14 PM ET
Size
5.6 KB
Accession
0001104659-22-096653
Insider Transaction Report
Form 4
Hagopian Henry III
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-08-29+120,000→ 120,000 totalExercise: $11.55Exp: 2032-08-29→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The stock option vests one-third on August 29, 2023 and the remaining two-thirds will vest in eight consecutive quarterly installments beginning the fifteenth month after August 29, 2022, and will vest in full upon a Change of Control (as defined in the Company's 2019 Equity Incentive Plan), with vesting conditioned on continued employment on the applicable vesting dates.
Documents
Issuer
Annovis Bio, Inc.
CIK 0001477845
Entity typeother
Related Parties
1- filerCIK 0001821822
Filing Metadata
- Form type
- 4
- Filed
- Aug 30, 8:00 PM ET
- Accepted
- Aug 31, 8:14 PM ET
- Size
- 5.6 KB